Global Gramicidin Market Growth 2025-2031

Publication ID:

LPI04255034

Publication Date:

April 23, 2025

Pages:

114

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Gramicidin market size is predicted to grow from US$ 368 million in 2025 to US$ 470 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.
Gramicidin, also called听gramicidin D, is a mix of听ionophoric听antibiotics,听gramicidin A,听B听and听C, which make up about 80%, 5%, and 15% of the mix, respectively
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淕ramicidin Industry Forecast鈥� looks at past sales and reviews total world Gramicidin sales in 2024, providing a comprehensive analysis by region and market sector of projected Gramicidin sales for 2025 through 2031. With Gramicidin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gramicidin industry.
This Insight Report provides a comprehensive analysis of the global Gramicidin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gramicidin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Gramicidin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gramicidin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gramicidin.
This report presents a comprehensive overview, market shares, and growth opportunities of Gramicidin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Liquid
Ointment
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bausch and Lomb
Amring Pharma
AbbVie
Bimeda
Bristol Myers Squibb
Dow Pharma
ERFA Canada
Euro Pharm
IPharma
Johnson and Johnson
Odan Laboratories
Pfizer
Sifi
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gramicidin market?
What factors are driving Gramicidin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gramicidin market opportunities vary by end market size?
How does Gramicidin break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gramicidin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gramicidin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gramicidin by Country/Region, 2020, 2024 & 2031
2.2 Gramicidin Segment by Type
2.2.1 Liquid
2.2.2 Ointment
2.3 Gramicidin Sales by Type
2.3.1 Global Gramicidin Sales Market Share by Type (2020-2025)
2.3.2 Global Gramicidin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gramicidin Sale Price by Type (2020-2025)
2.4 Gramicidin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gramicidin Sales by Application
2.5.1 Global Gramicidin Sale Market Share by Application (2020-2025)
2.5.2 Global Gramicidin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gramicidin Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Gramicidin Breakdown Data by Company
3.1.1 Global Gramicidin Annual Sales by Company (2020-2025)
3.1.2 Global Gramicidin Sales Market Share by Company (2020-2025)
3.2 Global Gramicidin Annual Revenue by Company (2020-2025)
3.2.1 Global Gramicidin Revenue by Company (2020-2025)
3.2.2 Global Gramicidin Revenue Market Share by Company (2020-2025)
3.3 Global Gramicidin Sale Price by Company
3.4 Key Manufacturers Gramicidin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gramicidin Product Location Distribution
3.4.2 Players Gramicidin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Gramicidin by Geographic Region
4.1 World Historic Gramicidin Market Size by Geographic Region (2020-2025)
4.1.1 Global Gramicidin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gramicidin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gramicidin Market Size by Country/Region (2020-2025)
4.2.1 Global Gramicidin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gramicidin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gramicidin Sales Growth
4.4 APAC Gramicidin Sales Growth
4.5 Europe Gramicidin Sales Growth
4.6 Middle East & Africa Gramicidin Sales Growth
5 Americas
5.1 Americas Gramicidin Sales by Country
5.1.1 Americas Gramicidin Sales by Country (2020-2025)
5.1.2 Americas Gramicidin Revenue by Country (2020-2025)
5.2 Americas Gramicidin Sales by Type (2020-2025)
5.3 Americas Gramicidin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gramicidin Sales by Region
6.1.1 APAC Gramicidin Sales by Region (2020-2025)
6.1.2 APAC Gramicidin Revenue by Region (2020-2025)
6.2 APAC Gramicidin Sales by Type (2020-2025)
6.3 APAC Gramicidin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gramicidin by Country
7.1.1 Europe Gramicidin Sales by Country (2020-2025)
7.1.2 Europe Gramicidin Revenue by Country (2020-2025)
7.2 Europe Gramicidin Sales by Type (2020-2025)
7.3 Europe Gramicidin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gramicidin by Country
8.1.1 Middle East & Africa Gramicidin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gramicidin Revenue by Country (2020-2025)
8.2 Middle East & Africa Gramicidin Sales by Type (2020-2025)
8.3 Middle East & Africa Gramicidin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gramicidin
10.3 Manufacturing Process Analysis of Gramicidin
10.4 Industry Chain Structure of Gramicidin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gramicidin Distributors
11.3 Gramicidin Customer
12 World Forecast Review for Gramicidin by Geographic Region
12.1 Global Gramicidin Market Size Forecast by Region
12.1.1 Global Gramicidin Forecast by Region (2026-2031)
12.1.2 Global Gramicidin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gramicidin Forecast by Type (2026-2031)
12.7 Global Gramicidin Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Bausch and Lomb
13.1.1 Bausch and Lomb Company Information
13.1.2 Bausch and Lomb Gramicidin Product Portfolios and Specifications
13.1.3 Bausch and Lomb Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bausch and Lomb Main Business Overview
13.1.5 Bausch and Lomb Latest Developments
13.2 Amring Pharma
13.2.1 Amring Pharma Company Information
13.2.2 Amring Pharma Gramicidin Product Portfolios and Specifications
13.2.3 Amring Pharma Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Amring Pharma Main Business Overview
13.2.5 Amring Pharma Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie Gramicidin Product Portfolios and Specifications
13.3.3 AbbVie Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 Bimeda
13.4.1 Bimeda Company Information
13.4.2 Bimeda Gramicidin Product Portfolios and Specifications
13.4.3 Bimeda Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bimeda Main Business Overview
13.4.5 Bimeda Latest Developments
13.5 Bristol Myers Squibb
13.5.1 Bristol Myers Squibb Company Information
13.5.2 Bristol Myers Squibb Gramicidin Product Portfolios and Specifications
13.5.3 Bristol Myers Squibb Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bristol Myers Squibb Main Business Overview
13.5.5 Bristol Myers Squibb Latest Developments
13.6 Dow Pharma
13.6.1 Dow Pharma Company Information
13.6.2 Dow Pharma Gramicidin Product Portfolios and Specifications
13.6.3 Dow Pharma Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Dow Pharma Main Business Overview
13.6.5 Dow Pharma Latest Developments
13.7 ERFA Canada
13.7.1 ERFA Canada Company Information
13.7.2 ERFA Canada Gramicidin Product Portfolios and Specifications
13.7.3 ERFA Canada Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 ERFA Canada Main Business Overview
13.7.5 ERFA Canada Latest Developments
13.8 Euro Pharm
13.8.1 Euro Pharm Company Information
13.8.2 Euro Pharm Gramicidin Product Portfolios and Specifications
13.8.3 Euro Pharm Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Euro Pharm Main Business Overview
13.8.5 Euro Pharm Latest Developments
13.9 IPharma
13.9.1 IPharma Company Information
13.9.2 IPharma Gramicidin Product Portfolios and Specifications
13.9.3 IPharma Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 IPharma Main Business Overview
13.9.5 IPharma Latest Developments
13.10 Johnson and Johnson
13.10.1 Johnson and Johnson Company Information
13.10.2 Johnson and Johnson Gramicidin Product Portfolios and Specifications
13.10.3 Johnson and Johnson Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Johnson and Johnson Main Business Overview
13.10.5 Johnson and Johnson Latest Developments
13.11 Odan Laboratories
13.11.1 Odan Laboratories Company Information
13.11.2 Odan Laboratories Gramicidin Product Portfolios and Specifications
13.11.3 Odan Laboratories Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Odan Laboratories Main Business Overview
13.11.5 Odan Laboratories Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Gramicidin Product Portfolios and Specifications
13.12.3 Pfizer Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Sifi
13.13.1 Sifi Company Information
13.13.2 Sifi Gramicidin Product Portfolios and Specifications
13.13.3 Sifi Gramicidin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Sifi Main Business Overview
13.13.5 Sifi Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂